IVAX GETS FINAL APPROVAL FOR GENERIC HYPERTENSION TABLETS.
IVAX Corporation, headquartered in Miami, Florida, is a holding company with subsidiaries engaged in the research, development, manufacturing, and marketing of branded and generic pharmaceuticals and veterinary and diagnostic products in the U.S. and international markets.
For more information, call 305/575-6043 or visit http://www.ivax.com.
|Printer friendly Cite/link Email Feedback|
|Date:||Nov 1, 2000|
|Previous Article:||BOSTON PROBES GETS PATENT FOR PNA PROBE TECHNOLOGY.|
|Next Article:||INTEGRA GETS GRANT TO DEVELOP RGD TECHNOLOGY.|
|FDA GIVES TENTATIVE APPROVAL FOR GENERIC VERSION OF PROZAC.|
|FAULDING TO MARKET ENALAPRILAT INJECTION/ENALAPRIL TABLETS.|
|IVAX GETS FINAL FDA APPROVAL FOR TAMOXIFEN ANDA.|